Cogent Biosciences, Inc. logo

Cogent Biosciences, Inc.

NASDAQ:COGT

Overview | Financials
Company Name Cogent Biosciences, Inc.
Symbol COGT
Currency USD
Price 10.47
Market Cap 1,145,941,500
Dividend Yield 0%
52-week-range 3.67 - 12.485
Industry Biotechnology
Sector Healthcare
CEO Mr. Andrew R. Robbins M.B.A.
Website https://www.cogentbio.com

An error occurred while fetching data.

About Cogent Biosciences, Inc.

Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in

Related Stocks

KalVista Pharmaceuticals, Inc. logo

KalVista Pharmaceuticals, Inc.

KALV

12.34 USD

VistaGen Therapeutics, Inc. logo

VistaGen Therapeutics, Inc.

VTGN

3.25 USD

VBI Vaccines Inc. logo

VBI Vaccines Inc.

VBIV

0.065 USD

Zentek Ltd. logo

Zentek Ltd.

ZTEK

1.25 USD

Prelude Therapeutics Incorporated logo

Prelude Therapeutics Incorporated

PRLD

4.85 USD

bluebird bio, Inc. logo

bluebird bio, Inc.

BLUE

0.529 USD

Viemed Healthcare, Inc. logo

Viemed Healthcare, Inc.

VMD

7.33 USD

MacroGenics, Inc. logo

MacroGenics, Inc.

MGNX

3.25 USD

Singular Genomics Systems, Inc. logo

Singular Genomics Systems, Inc.

OMIC

5.892 USD

PepGen Inc. logo

PepGen Inc.

PEPG

8.83 USD

Financials

Numbers are in millions USD

Numbers are in millions USD